Effect of Motor Function, Depression and Sleep Quality on Attention in Parkinson's Disease
Launched by INONU UNIVERSITY · Feb 21, 2024
Trial Information
Current as of July 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Parkinson's Disease (PD) is a neurodegenerative disease that occurs with the loss of dopaminergic neurons in the basal ganglia (BG) and subsequently affects multiple brain regions. There are studies that evaluate executive functions rather than cognitive functions in Parkinson's patients. However, objective evaluations of the attention parameter are quite rare. Accordingly, our study was planned to examine the effects of motor function, depression and sleep on attention in Parkinson's patients with detailed and objective measurements. Parkinson's patients (n=27) and healthy controls (n=27) ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Being 1,2 or 3 according to the Hoehn and yahr scale
- • Being between the ages of 40-85
- • Being diagnosed with Parkinson's according to UPDS
- • Being able to read and write
- • Being able to walk independently
- • Agreeing to participate in the study after providing detailed information about the research.
- • Mini mental test\>24
- Exclusion Criteria:
- • Having severe hearing/visual impairment-loss
- • Having an orthopedic, neurological or metabolic disease that may interfere with working
- • Having deep brain stimulation applied
- • Those with advanced cognitive impairment
- • Individuals with dementia
- • Patients taking anticholinergic, antidepressive or anxiolytic medications that may affect cognition, and those with other medical or neurological causes that may cause cognitive effects.
About Inonu University
Inonu University is a prominent academic institution located in Turkey, dedicated to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive resources and expertise to facilitate innovative research initiatives aimed at improving patient care and advancing scientific knowledge. With a strong commitment to ethical standards and regulatory compliance, Inonu University collaborates with various stakeholders, including healthcare professionals and industry partners, to conduct rigorous clinical trials that contribute to the development of new therapies and treatment modalities. Through its research endeavors, the university strives to enhance healthcare outcomes and foster a culture of inquiry within the medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Malatya, Battalgazi, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported